Various symptoms indicate chronic myelogenous leukemia (CML) has progressed from one phase to another. These include an increase in leukemia cells, a change in a person’s platelet count, and worsening ...

Glitazones, a class of drug commonly used to treat diabetes, may help eradicate residual cancer cells in chronic myelogenous leukemia (CML), according to a study published online September 2 in Nature ...

Chronic myelogenous leukemia (CML) is a cancer that affects your blood cells and bone marrow -- the soft part inside your bones where blood cells are made. You may also hear your doctor call it ...

According to the Company, the product is expected to be available in the coming weeks through Biologics by McKesson and Limited Specialty Distribution. The Food and Drug Administration (FDA) has ...

Study design and treatment strategy have been published previously. 3, 8 In brief, newly diagnosed CML patients in chronic phase (CP) were randomized into a 5-arm study comparing IM400 mg/day vs IM400 ...

Genetic testing for chronic myeloid leukemia (CML) can tell doctors if someone has leukemia, what type they may have, and whether treatment is working. The tests look for atypical changes in certain ...

A study from a major cancer center collected data on 2857 patients with Ph+ CML, most of whom were White and middle-aged. Ten-year overall survival for patients with Ph+ CML treated since 2000 was ...

Survival (prognosis) for chronic myeloid leukaemia (CML) depends on several factors such as age. No one can tell you exactly how long you will live. CML is usually a slowly developing condition and ...

To evaluate the role of Hh signalling in CML, Reya and colleagues developed mice that lacked expression of smoothened (SMO), the transmembrane protein that transmits Hh signals, in haematopoietic ...